Cécile L. Berends

MicroRNA‐122 can be measured in capillary blood which facilitates point‐of‐care testing for drug‐induced liver injury

A. D. Bastiaan Vliegenthart, Cécile L. Berends, Carmelita M. J. de Potter et al. · British Journal of Clinical Pharmacology · 2017 · 37 citations · Full text

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement

Michelle Mellion, Lucienne Ronco, Cécile L. Berends et al. · British Journal of Clinical Pharmacology · 2021 · 37 citations · Full text

Characterization of Triptolide-Induced Hepatotoxicity by Imaging and Transcriptomics in a Novel Zebrafish Model

A. D. Bastiaan Vliegenthart, Chunmin Wei, Charlotte Buckley et al. · Toxicological Sciences · 2017 · 25 citations · Full text

Triptolide Exposure, Triptolide-induced Hepatotoxicity, Zebrafish Larvae +15

First‐in‐human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR‐324, a dual enkephalinase inhibitor for pain management

Laurence Moss, Cécile L. Berends, Emilie M.J. van Brummelen et al. · British Journal of Clinical Pharmacology · 2021 · 13 citations · Full text

Validation of a pharmacological model for mitochondrial dysfunction in healthy subjects using simvastatin: A randomized placebo-controlled proof-of-pharmacology study

Marcus P.J. van Diemen, Cécile L. Berends, Joep Wezel et al. · European Journal of Pharmacology · 2017 · 12 citations

Metabolic Syndrome, Heart Failure, Healthy Subjects +13